ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension
Lai‐Ming Yung(Massachusetts General Hospital), Paul B. Yu(University of Oxford), Mark Southwood(Papworth Hospital), Teresa Dinter(IIT@MIT), Iván O. Rosas(Brigham and Women's Hospital), Dianne Sako(University of Washington), Luca Troncone(Harvard University), Peiran Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zachary M. Augur(Brigham and Women's Hospital), Sergio Poli(Brigham and Women's Hospital), Sachindra Raj Joshi(Bowling Green State University), John L. Knopf(Acceleron Pharma (United States)), Megan McNeil(Brigham and Women's Hospital), Geoffrey A. Bocobo(Brigham and Women's Hospital), Gang Li(Acceleron Pharma (United States)), Stephanie S. Kim(Boston Children's Hospital), R. Scott Pearsall(Acceleron Pharma (United States)), Po-Sheng Chen(Brigham and Women's Hospital), Ravindra Kumar(Acceleron Pharma (United States)), John D. Quisel(Acceleron Pharma (United States))
Cited by 240
Related Papers
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
|Science Advances|2020|1.5k
Collagen-producing lung cell atlas identifies multiple subsets with distinct localization and relevance to fibrosis
|Nature Communications|2020|780
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
|The Journal of Experimental Medicine|2010|740
Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities
|New England Journal of Medicine|2011|615
MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis
|PLoS Medicine|2008|599